Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Acceptability of a Digital Therapeutic for Adolescent Depressive Symptoms in Hematology/Oncology and Weight Management

NCT05351866 is registered in ClinicalTrials.gov with Limbix Health, Inc. as lead sponsor.

NCT NCT05351866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05351866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Acceptability of a Digital Therapeutic for Adolescent Depressive Symptoms in Hematology/Oncology and Weight Management
Lead sponsor
Limbix Health, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
January 26, 2023
Completion date
June 26, 2023
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adolescent - emotional problem, adolescent behavior, depression, depressive disorder, depressive episode, depressive symptoms, hematologic diseases, oncology, weight, body